Search
for
Sort by
Research 421–450 of 1000+
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- The association between Interleukin (IL)-4 gene intron 3 VNTR polymorphism and alopecia areata (AA) in Turkish population
- Acquired immunogenicity of DNA after modification with malondialdehyde in patients with alopecia areata
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Investigation of Vaspin and Visfatin -4689G/T Gene Polymorphisms in Alopecia Areata Patients
- Diagnosis and treatment of alopecia areata
- Association between epidermal growth factor and epidermal growth factor receptor gene polymorphisms and susceptibility to alopecia areata in Korean population
- Analysis of Serum Zinc and Copper Concentrations in Hair Loss
- Alopecia areata incognita: A Hypothesis
- Tofacitinib for the treatment of alopecia areata in preadolescent children
- Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine
- A Spontaneous Deletion within the Desmoglein 3 Extracellular Domain of Mice Results in Hypomorphic Protein Expression, Immunodeficiency, and a Wasting Disease Phenotype
- Biomarkers in alopecia Areata: A systematic review and meta-analysis.
- The evaluation of IL-4 VNTR intron 3 and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with alopecia areata: a case–control study
- Genetic Association Between Polycystic Ovary Syndrome and the <i>APOA5</i> rs662799 and <i>PLIN1</i> rs894160 Metabolic Variants in the Western Saudi Population: A Case-Control Study
- The evaluation of IL-4 intron 3 VNTR and TNF-α (rs1799964) gene polymorphisms in Egyptian patients with Alopecia Areata: a case-control study
- ALOPESIA AREATA DENGAN TERAPI KOMBINASI INJEKSI PLATELET-RICH PLASMA (PRP) DAN TRIAMSINOLON ASETONID INTRALESI
- Alopecia Areata: Why is it Areata?
- A novel therapeutic paradigm for patients with extensive alopecia areata
- Treatment of alopecia areata in pre‐adolescent children with oral tofacitinib: A retrospective study
- rs4541843 G > A variant near miR-182 is associated with susceptibility, severity, and increased hsa-miR-182-5p expression in alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Advances in the management of alopecia areata
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Psychosomatic aspects of alopecia areata
- Differential proteomics of lesional vs. non-lesional biopsies revealed non-immune mechanisms of alopecia areata
- Efficacy and safety of superficial cryotherapy for alopecia areata: A retrospective, comprehensive review of 353 cases over 22 years
- Preferential Recognition of Hydroxyl Radical-Modified Superoxide Dismutase by Circulating Autoantibodies in Patients with Alopecia Areata
- Association of vitamin D level with alopecia areata
- Alopecia areata – hyperactivity of the hypothalamic–pituitary–adrenal axis is a myth?